Jul 14, 2026, 01:00 by User Not Found

Clinical Research News | An experimental artificial intelligence (AI) model called OCTCube-M could help improve patient selection, predict disease progression, and streamline clinical trials by extracting new insights from three-dimensional optical coherence tomography (OCT) eye scans.

Jul 13, 2026, 10:05 by

The FDA has approved Sanofi's Sarclisa Escena, making it the first anticancer therapy that can be administered through a wearable on-body injector. Clinical studies showed the new subcutaneous treatment delivers effectiveness comparable to intravenous therapy while reducing administration time and infusion-related reactions. The approval is expected to improve both patient convenience and healthcare workflow in the treatment of multiple myeloma.

Jul 13, 2026, 10:05 by

• Strengthens multiomics portfolio offering metabolite-level insight to connect molecular data with biological function across broader life science studies • New workflow built around Thermo Scientific Vanquish UHPLC coupled with Orbitrap Exploris 120 high-resolution accurate-mass mass spectrometry

Jul 9, 2026, 01:01 by User Not Found

Clinical Research News | Artificial intelligence agents are beginning to reshape clinical trial operations, but sponsors are still hesitating. Raj Indupuri, CEO of eClinical Solutions, joined the latest episode of The Scope of Things, hosted by Deborah Borfitz, to break down the three main obstacles hindering AI adoption: data readiness, governance and trust, and operating model change.

Jul 8, 2026, 10:38 by

Novartis has agreed to acquire UK-based biotech company Myricx Bio in a deal worth up to USD 1.5 billion to strengthen its oncology pipeline. The acquisition brings Myricx's next-generation NMTi antibody-drug conjugate (ADC) platform, designed to overcome resistance to existing cancer therapies. It also adds two lead ADC candidates targeting B7-H3 and HER2, expanding Novartis' portfolio for treating solid tumors. The transaction is expected to close in the second half of 2026, subject to regulatory approvals.

Jul 8, 2026, 10:38 by

Jul 8, 2026, 10:38 by

FDA Clears CliniComp PACS Viewer (MIMPS), Unifying Diagnostic Imaging, Enterprise EHR, and Native AI in a Single Platform

Jul 8, 2026, 10:38 by

New proprietary capability enhances ProPharma’s regulatory service delivery model, helping clients accelerate submission development while maintaining the highest standards of quality and compliance.

Jul 8, 2026, 10:38 by

New research demonstrates RBQM-enabled trials achieve up to 23x ROI and 19% shorter phase durations, providing the industry’s first quantitative business case for risk-based oversight in clinical development

Jul 8, 2026, 01:01 by User Not Found

Clinical Research News | Insilico Medicine is launching a phase III clinical program for rentosertib, its potentially first-in-class oral small-molecule inhibitor of TNIK (TRAF2- and NCK-interacting kinase) for the treatment of idiopathic pulmonary fibrosis (IPF), a progressive, age-related fibrotic lung disease with high unmet medical need. It is the next step in making AI-discovered drugs a reality for patients.

Jul 7, 2026, 08:51 by

ECI has announced the appointment of Taranjit S. Samra, DRSc, MSEE, RAC, as Head of Medical Device Software Engineering, Cybersecurity and AI.

Jul 2, 2026, 07:11 by

Jul 1, 2026, 09:05 by

Enhancements further break down silos and reduce fragmentation through integrated risk and quality management within one clinical data intelligence platform

Jul 1, 2026, 09:05 by

Jul 1, 2026, 09:05 by

Jul 1, 2026, 01:01 by User Not Found

Clinical Research News | cAMPfield is launching a global phase 2b trial for moderate-to-severe ulcerative colitis and a global phase 2 for Crohn’s disease; Gero intends to advance a portfolio of both disease-modifying and aging-slowing programs in parallel; ClearNote Health continues commercial clinical study execution and broader global access; and more.

Jun 30, 2026, 01:01 by User Not Found

Clinical Research News | The Ellison Medical Institute enters an exclusive license with UniQuest; TrialAssure and Cancer Research UK’s Centre for Drug Development announce new partnership; EndoDNA launches BIOS, a clinical decision-support; and more.

Jun 26, 2026, 01:01 by User Not Found

Clinical Research News | India has long been called the pharmacy of the world. That reputation was earned through manufacturing scale, generics leadership, and the ability to supply medicines globally at extraordinary volume. But the next chapter for India’s pharmaceutical industry will be different. Recent industry discussion about India’s pharmaceutical ambitions has largely explored one question: Can India compete with China as a global pharmaceutical power?

Jun 24, 2026, 09:17 by

Eli Lilly has launched a nationwide awareness campaign featuring basketball legend Shaquille O'Neal to highlight the risks of moderate-to-severe obstructive sleep apnea (OSA). After learning that years of fatigue, loud snoring, and poor sleep were symptoms of OSA, O'Neal began treatment with Zepbound® (tirzepatide). The campaign encourages people experiencing sleep apnea symptoms to seek medical advice and explore treatment options. Zepbound is the first FDA-approved prescription medicine for adults with obesity and moderate-to-severe OSA, helping improve sleep quality and reduce breathing interruptions during sleep.

Jun 23, 2026, 01:01 by User Not Found

Clinical Research News | In mid-June Novo Nordisk announced, “an IT security incident involving unauthorized access to a limited number of internal IT systems” that exposed personal information for clinical trial participants. Novo Nordisk listed the exposed data categories as Patient ID (random alphanumeric string) and information on trial participation; sex; year of birth; biomarkers; health/immunogenicity data; and lifestyle factors including smoking, alcohol use, and BMI.